Course Description:This webinar series will update you on the latest USP developments in Particulate Matters.
This webinar will focus on USP General Chapter <771> and the applicability of USP’s visible (<790>) and subvisible (<788> and <789>) standards to ophthalmic drug products. Discussions will cover the evolution of USP chapters, methods and requirements, concepts of method qualification, and other technical considerations. Participants will be offered the opportunity to ask questions during the last segment of the session.
Who should participate:
- Laboratory scientists
- Lab managers
- QA/QC staff in the pharmaceutical and allied industries
- Regulatory professionals
- Scientists with interest in Particulate Matter
The live version of this recording took place on December 14, 2022
Access Duration:
Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.
Speakers:
D. Scott Aldrich
USP Dosage Forms Expert Committee
B.S., Western Michigan University
Mary Lee Ciolkowski
USP <1790> & <788> Expert Panels
Ph.D., University of North Carolina at Chapel Hill
Desmond Hunt
Senior Principal Scientist, USP
Ph.D., University of Texas, Austin
Margareth Marques
Senior Principal Scientist, USP
Ph.D., University of Campinas, Brazil